These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25394242)

  • 21. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
    Buhimschi IA; Zhao G; Pettker CM; Bahtiyar MO; Magloire LK; Thung S; Fairchild T; Buhimschi CS
    Am J Obstet Gynecol; 2007 Feb; 196(2):181.e1-13. PubMed ID: 17306673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
    Opatrna S; Popperlova A; Kalousová M; Zima T
    Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
    Oesterle A; Bowman MA
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ventilator bundle treatment of acute respiratory distress syndrome and its correlation with biomarkers of inflammation].
    Yang J; Dong C; Li J; Zhang H; Zhang H; Song R; Yang Z; Feng F; Qi Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Aug; 26(8):544-8. PubMed ID: 25124901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher body mass index predicts need for insulin but not hyperglycemia, nosocomial infection, or death in critically ill surgical patients.
    Pieracci F; Hydo L; Eachempati S; Pomp A; Shou J; Barie PS
    Surg Infect (Larchmt); 2008 Apr; 9(2):121-30. PubMed ID: 18426344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.
    Kim HS; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    Nephrology (Carlton); 2013 Dec; 18(12):777-82. PubMed ID: 24124651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.
    Nakashima A; Carrero JJ; Qureshi AR; Miyamoto T; Anderstam B; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2213-9. PubMed ID: 20847094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
    BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients.
    Jung ES; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    J Korean Med Sci; 2017 Jan; 32(1):54-59. PubMed ID: 27914132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose control and mortality in critically ill patients.
    Finney SJ; Zekveld C; Elia A; Evans TW
    JAMA; 2003 Oct; 290(15):2041-7. PubMed ID: 14559958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature review.
    Marsh AM; Nguyen AH; Parker TM; Agrawal DK
    Can J Physiol Pharmacol; 2017 Mar; 95(3):253-259. PubMed ID: 28092162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients.
    Isoyama N; Machowska A; Qureshi AR; Yamamoto T; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    Perit Dial Int; 2016; 36(3):269-76. PubMed ID: 26493750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus.
    Skrha J; Kalousová M; Svarcová J; Muravská A; Kvasnička J; Landová L; Zima T; Skrha J
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):277-81. PubMed ID: 22549347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of damage-associated molecular patterns to transfusion-related acute lung injury in cardiac surgery.
    Müller MC; Tuinman PR; Vlaar AP; Tuip AM; Maijoor K; Achouiti A; Van t Veer C; Vroom MB; Juffermans NP
    Blood Transfus; 2014 Jul; 12(3):368-75. PubMed ID: 24887223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
    Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
    Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands.
    Yao D; Brownlee M
    Diabetes; 2010 Jan; 59(1):249-55. PubMed ID: 19833897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival.
    Thiessen SE; Vanhorebeek I; Derese I; Gunst J; Van den Berghe G
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1319-27. PubMed ID: 26274346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Yamada S; Takeuchi M; Fukami K; Ueda S; Adachi H; Matsui T; Okuda S; Yamagishi S
    Metabolism; 2009 Nov; 58(11):1624-8. PubMed ID: 19604520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes.
    Huang SM; Chang YH; Chao YC; Lin JA; Wu CH; Lai CY; Chan KC; Tseng ST; Yen GC
    Mol Nutr Food Res; 2013 Dec; 57(12):2264-8. PubMed ID: 23901023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.